search
Back to results

Madagascar Female Condom Study

Primary Purpose

Sexually Transmitted Diseases

Status
Completed
Phase
Phase 3
Locations
Madagascar
Study Type
Interventional
Intervention
Clinic-based counseling
Sponsored by
FHI 360
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional educational/counseling/training trial for Sexually Transmitted Diseases focused on measuring AE adverse event, DCF data collection forms, IRB Institutional Review Board, SAE serious adverse event

Eligibility Criteria

0 Years - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Adult female sex workers from the two sites Exclusion Criteria: None specified

Sites / Locations

  • Isotry Health Center
  • Dispensaire Kelly

Outcomes

Primary Outcome Measures

Use of protection (male and female condoms)
STIs

Secondary Outcome Measures

Full Information

First Posted
January 4, 2006
Last Updated
January 4, 2006
Sponsor
FHI 360
Collaborators
Ministry of Health, Madagascar, National Reference Laboratory, Madagascar, University of North Carolina
search

1. Study Identification

Unique Protocol Identification Number
NCT00272974
Brief Title
Madagascar Female Condom Study
Official Title
Measuring the Impact of Male and Female Condom Promotion Among Commercial Sex Workers in Madagascar
Study Type
Interventional

2. Study Status

Record Verification Date
August 2003
Overall Recruitment Status
Completed
Study Start Date
February 2001 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2003 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
FHI 360
Collaborators
Ministry of Health, Madagascar, National Reference Laboratory, Madagascar, University of North Carolina

4. Oversight

5. Study Description

Brief Summary
The study was designed to measure the effects of male and female condom promotion on STI prevalence and reported condom use by sex workers and their partners. It also examined whether the intensity of the education and support given to intended users affected adoption and sustained use of these methods. The primary objective of the study was: To test the effect of supplementing community-based male and female condom promotion with clinic-based counseling, measured in terms of the level of protection in high-risk sex acts and STI prevalence. Secondary objectives of the study included: To monitor short- and medium terms changes in the proportion of protected sex acts among commercial sex workers after the female condom is added to a male condom distribution system. To examine short-term and medium-term changes in STI prevalence when the female condom is added to the male condom distribution system. To measure the incremental cost-effectiveness of adding female condom promotion to existing male condom distribution systems
Detailed Description
This three-phased study examined ways to improve services for the prevention of STIs among commercial sex workers. This study was conducted in identical fashion in two sites (Tamatave and Antananarivo) in Madagascar. It tested whether condom promotion through community-based counseling or clinic based counseling leads to an increased level of protection among high-risk sex acts and a subsequent decrease in STI infection rates. In Phase I, women at each site were randomly assigned to a study arm receiving a community-based male condom promotion intervention, or a study arm receiving community-based male condom promotion supplemented with clinic-based counseling. Randomization was accomplished by the use of sequentially-numbered sealed, opaque envelopes containing the group assignment. The randomization list was stratified by study site. Phase I began with baseline measurement of male condom use and STI prevalence. Participants returned three times, at two month intervals, for follow-up. At each visit, face-to-face interviews were conducted to estimate the proportion of protected sex acts. At the third visit only, participants were tested for gonococcal, chlamydial, and trichomonal infections. This reliance on a combination of biologic and behavioral outcomes helped to reduce any bias brought on by the inherent limitations of either of these measures on its own. Half the women completing Phase I at each site were then randomized to a Phase II study arm receiving a community-based male and female condom promotion intervention, while the other half entered Phase II receiving the same community-based male and female condom promotion supplemented with clinic-based counseling. This sequential randomization scheme allowed measurement of the short-term (within 6 months) effect of clinic-based counseling on male condom use and STI prevalence, and the short-term effect of clinic-based counseling on male condom + female condom use and STI prevalence. A similar data collection process was used, with measurement of male and female condom use in all three visits, and STI testing in the third visit only. In Phase III, participants were followed for an additional 6 months, in the same intervention group to which they were assigned at the beginning of Phase II, to assess the medium-term impacts of the female condom, after participants had a chance to become accustomed to the female condom.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sexually Transmitted Diseases
Keywords
AE adverse event, DCF data collection forms, IRB Institutional Review Board, SAE serious adverse event

7. Study Design

Primary Purpose
Educational/Counseling/Training
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1000 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Clinic-based counseling
Primary Outcome Measure Information:
Title
Use of protection (male and female condoms)
Title
STIs

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
0 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adult female sex workers from the two sites Exclusion Criteria: None specified
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Theresa Hatzell, PhD, MPH
Organizational Affiliation
FHI 360
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Paul Feldblum, PhD
Organizational Affiliation
FHI 360
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Kathleen Van Damme, MD
Organizational Affiliation
FHI 360
Official's Role
Principal Investigator
Facility Information:
Facility Name
Isotry Health Center
City
Antananarivo
Country
Madagascar
Facility Name
Dispensaire Kelly
City
Tamatave
Country
Madagascar

12. IPD Sharing Statement

Links:
URL
http://www.fhi.org
Description
Related Info

Learn more about this trial

Madagascar Female Condom Study

We'll reach out to this number within 24 hrs